« Previous
Next »
Psychiatry Research: Neuroimaging
Volume 139, Issue 3
, Pages 165-179
, 30 August 2005
Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: An exploratory approach
References
- . Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies. European Journal of Nuclear Medicine. 1998;25:663–667
- . Investigation into the mechanisms of vagus nerve stimulation for the treatment of intractable epilepsy, using 99mTc–HMPAO SPET brain images. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30:301–305
- . Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurology. 2002;1:477–482
- . Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI. Investigative Radiology. 2001;36:470–479
- . Cerebral blood flow in depressed patients: a methodological comparison of statistical parametric mapping and region of interest analyses. Psychiatry Research: Neuroimaging. 2003;122:49–57
- . Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Research: Neuroimaging. 1999;91:127–139
- . Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy. Archives of General Psychiatry. 2001;58:631–640
- . Effect of sertraline on regional metabolic rate in patients with affective disorder. Biological Psychiatry. 1997;41:15–22
- . SPECT mapping of cerebral activity changes induced by repetitive transcranial magnetic stimulation in depressed patients. A pilot study. Psychiatry Research: Neuroimaging. 2001;106:151–160
- . A review of functional neuroimaging studies of vagus nerve stimulation (VNS). Journal of Psychiatric Research. 2003;37:443–455
- . Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression. American Journal of Psychiatry. 2003;160:374–376
- . Prefrontal cortical–amygdalar metabolism in major depression. Annals of the New York Academy of Sciences. 1999;877:614–637
- . Neuroimaging studies of mood disorders. Biological Psychiatry. 2000;48:813–829
- . Neuroimaging and neuropathological studies of depression: implications for the cognitive–emotional features of mood disorders. Current Opinion in Neurobiology. 2001;11:240–249
- . Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997;386:824–827
- . Neuroimaging studies of depression. In: Charney DS, Nestler EJ, Bunney BJ editor. Neurobiology of Mental Illness. New York: Oxford University Press; 1999;p. 394–418
- . Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology. 2002;12:527–544
- . Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping. 1995;2:189–210
- . Vagus nerve stimulation: a new tool for brain research and therapy. Biological Psychiatry. 2000;47:287–295
- . Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia. 1998;39:983–990
- . Characterising brain images with the general linear model. In: Frackowiak RS editors. Human Brain Function. San Diego: Academic Press; 1997;p. 59–84
- . Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography. European Journal of Nuclear Medicine. 1997;24:670–673
- . Cerebral blood flow changes in the primary motor and premotor cortices during hyperventilation. Annals of Nuclear Medicine. 1998;12:29–33
- . Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. American Journal of Psychiatry. 2001;158:899–905
- . Evaluation of brain perfusion with technetium-99m bicisate single-photon emission tomography in patients with depressive disorder before and after drug treatment. European Journal of Nuclear Medicine. 1998;25:1412–1414
- . Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. American Journal of Psychiatry. 2002;159:1830–1840
- . Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. Journal of Psychiatric Research. 2002;36:219–227
- . Brain mapping with single photon emission CT. Radiology. 1998;206:483–489
- . Vagus nerve stimulation and refractory depression: please can you switch me on doctor?. British Journal of Psychiatry. 2003;183:181–183
- . Modulating dysfunctional limbic–cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin. 2003;65:193–207
- . Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry. 2000;48:830–843
- . The functional neuroanatomy of the placebo effect. American Journal of Psychiatry. 2002;159:728–737
- . Modulation of the neuronal circuitry subserving working memory in healthy human subjects by repetitive transcranial magnetic stimulation. Neuroscience Letters. 2000;280:167–170
- . Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Research: Neuroimaging. 2002;115:1–14
- . Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability. Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 2002;15:159–175
- . Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. Journal of Neuropsychiatry and Clinical Neurosciences. 2001;13:459–470
- . Regional cerebral blood flow in mood disorders, V.: effects of antidepressant medication in late-life depression. American Journal of Geriatric Psychiatry. 2000;8:289–296
- . Structural and functional neuroimaging of electroconvulsive therapy and transcranial magnetic stimulation. Depression and Anxiety. 2000;12:144–156
- . Decreased regional brain metabolism after ECT. American Journal of Psychiatry. 2001;158:305–308
- . Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. American Journal of Psychiatry. 1999;156:190–194
- . Resistance to antidepressant medications and short-term clinical response to ECT. American Journal of Psychiatry. 1996;153:985–992
- . Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Research. 1990;31:287–296
- . A SPECT study of the effect of vagal nerve stimulation on thalamic activity in patients with epilepsy. Seizure. 2000;9:380–384
- . Effect of ECT on cerebral blood flow in melancholia assessed with SPECT. Convulsive Therapy. 1988;4:62–73
- . Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biological Psychiatry. 2000;47:276–286
- . The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. Journal of Clinical Psychopharmacology. 1990;10:96–104
- . Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;25:713–728
- . Differential cerebral metabolic changes with paroxetine treatment of obsessive–compulsive disorder vs major depression. Archives of General Psychiatry. 2002;59:250–261
- . Regional cerebral blood flow in depression and mania. Archives of General Psychiatry. 1989;46:253–259
- . Acute and late effects of electroconvulsive therapy. Clinical outcome, regional cerebral blood flow, and electroencephalogram. Annals of the New York Academy of Sciences. 1986;462:236–248
- . Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biological Psychiatry. 2000;48:1133–1141
- . Intensity-dependent regional cerebral blood flow during 1-Hz repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers studied with H215O positron emission tomography: I. Effects of primary motor cortex rTMS. Biological Psychiatry. 2003;54:818–825
- . European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using 99mTc-labelled radiopharmaceuticals. European Journal of Nuclear Medicine and Molecular Imaging. 2002;29:36–42
- . Vagus nerve stimulation in refractory epilepsy: SPECT activation study. Journal of Nuclear Medicine. 2000;41:1145–1154
- . Perfusion SPECT changes after acute and chronic vagus nerve stimulation in relation to prestimulus condition and long-term clinical efficacy. Journal of Nuclear Medicine. 2002;43:733–744
- . Acute single photon emission computed tomographic study of vagus nerve stimulation in refractory epilepsy. Epilepsia. 2000;41:601–609
- . 11C-diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping. Journal of Cerebral Blood Flow and Metabolism. 1997;17:943–949
PII: S0925-4927(05)00091-0
doi: 10.1016/j.pscychresns.2005.02.010
© 2005 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Psychiatry Research: Neuroimaging
Volume 139, Issue 3
, Pages 165-179
, 30 August 2005
